| Serial Number | 79203359 |
| Word Mark | SANBIO |
| Filing Date | Wednesday, October 26, 2016 |
| Status | 739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Monday, July 8, 2024 |
| Registration Number | 5377414 |
| Registration Date | Tuesday, January 16, 2018 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 31, 2017 |
| Description of Mark | The mark consists of the wording "SANBIO" in black with a light green triangle above the "I"; to the left of the wording is a dark green square with two light green bands inside the square and a third light green band partially outside the square. The color white represents background and is not a feature of the mark. |
| Goods and Services | Pharmaceutical, veterinary preparations and sanitary preparations for gene therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations for cell therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations for regenerative medicine for medical purposes; medicines for treating central nervous system diseases; pharmaceutical, veterinary preparations and sanitary preparations, namely, cells, stem cells and living cells for gene therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations, namely, cells, stem cells and living cells for cell therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations, namely, cells, stem cells and living cells for regenerative medicine for medical purposes |
| Pseudo Mark | SAN BIO |
| Indication of Colors claimed | The color(s) black, light green and dark green is/are claimed as a feature of the mark. |
| Goods and Services | Testing, inspection, research, development and evaluation services for others in the fields of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals; consulting services in the field of pharmaceutical research and development; and testing, inspection, research, or development of pharmaceutical preparations for gene therapy, cell therapy, regenerative medicine and medicines for treating central nervous system diseases; conducting clinical trials for others in the field of pharmaceutical products, providing medical and scientific research information in the field of pharmaceutical products, and consulting services in the field of pharmaceutical product research and development; conducting clinical trials for others, providing medical and scientific research information in the field of clinical trials, and consulting services for others in the field of design, planning, and implementation project management of clinical trials; medical research, compiling data for research purposes in the field of medical consultancy, and providing medical research information in the field of pharmaceuticals, gene therapy, cell therapy for medical purposes, regenerative medicine and medicines for treating central nervous system diseases; scientific research and development, scientific research, analysis, and testing in the field of pharmaceutical product development, gene therapy development, cell therapy for medical purposes development, regenerative medicine development and central nervous system diseases therapy development, consulting services in the field of pharmaceutical product research and development, gene therapy research and development, cell therapy for medical purposes research and development, regenerative medicine research and development and central nervous system diseases therapy medicine research and development, and providing scientific research information in the field of pharmaceuticals, gene therapy, cell therapy regenerative medicine and central nervous system diseases therapy medicine |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 17, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 17, 2017 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | SanBio Company Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Tokyo 104-0044 JP |
| Party Name | SanBio Company Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Tokyo 104-0044 JP |
| Party Name | SanBio Company Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Tokyo 104-0044 JP |
| Event Date | Event Description |
| Tuesday, March 21, 2017 | APPLICATION FILING RECEIPT MAILED |
| Thursday, March 16, 2017 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, March 17, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 17, 2017 | ASSIGNED TO EXAMINER |
| Saturday, March 25, 2017 | NON-FINAL ACTION WRITTEN |
| Sunday, March 26, 2017 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, March 28, 2017 | REFUSAL PROCESSED BY MPU |
| Tuesday, March 28, 2017 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, April 15, 2017 | REFUSAL PROCESSED BY IB |
| Monday, August 14, 2017 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, August 14, 2017 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, August 15, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, August 16, 2017 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Thursday, August 31, 2017 | ASSIGNED TO LIE |
| Saturday, September 2, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, September 2, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 25, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, September 25, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Monday, September 25, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, September 25, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Monday, September 25, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, September 26, 2017 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, October 11, 2017 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, October 11, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, October 11, 2017 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Sunday, October 29, 2017 | NOTIFICATION PROCESSED BY IB |
| Tuesday, October 31, 2017 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 31, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 16, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Monday, April 16, 2018 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Friday, April 20, 2018 | FINAL DISPOSITION PROCESSED |
| Friday, April 20, 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, June 15, 2018 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, January 16, 2023 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Tuesday, October 24, 2023 | TEAS SECTION 71 & 15 RECEIVED |
| Tuesday, July 2, 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Monday, July 8, 2024 | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. |
| Monday, July 8, 2024 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |